{
  "nctId": "NCT07175597",
  "briefTitle": "Pilot Trial of Hibiscus Drink During Pregnancy (PTHDDP)",
  "officialTitle": "Trial of Acceptability, Tolerability and Biochemical Indicators of Hibiscus Sabdariffa L. Drink in Pregnant Women",
  "protocolDocument": {
    "nctId": "NCT07175597",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2024-04-01",
    "uploadDate": "2025-09-09T08:24",
    "size": 1141373,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT07175597/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 10,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2024-04-30",
    "completionDate": "2025-06-30",
    "primaryCompletionDate": "2024-06-30",
    "firstSubmitDate": "2025-08-27",
    "firstPostDate": "2025-09-16"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Women in the second trimester of pregnancy (14 to 28 gestation weeks)\n* Age 18 to 35 years\n* Blood pressure \\<140/90 mmHg\n\nExclusion Criteria:\n\n* Multiple or high-risk pregnancy\n* Hypertensive disorder in previous pregnancies\n* Body mass index \\>32 kg/m2\n* Present chronic diseases",
    "healthyVolunteers": false,
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "maximumAge": "35 Years",
    "stdAges": [
      "ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Acceptability of Hibiscus sabdariffa drink",
        "description": "Beverage acceptability was measured using a sensory evaluation with 7-point hedonic scale of the attributes of odor, color, flavor, mouthfeel, aftertaste, and overall appearance through questionnaires applied once a week for 4 weeks.\n\nThe outcome measures are based on a 7-point hedonic scale where every participant can answer in every attribute evaluated:\n\n1. I dislike it a lot\n2. I dislike it moderately\n3. I dislike it a little\n4. I neither like it nor dislike it\n5. I like it a little\n6. I like it moderately\n7. I like it a lot",
        "timeFrame": "4 weeks"
      },
      {
        "measure": "Tolerability of Hibiscus sabdariffa Drink",
        "description": "Tolerability was measured by the presence or absence of gastrointestinal symptoms such as nausea, regurgitation, vomiting, constipation, diarrhea, flatulence, and abdominal pain through questionnaires applied once a week for 4 weeks.\n\nThe outcome measures for the tolerability assessment were the presence or absence of gastrointestinal symptoms mentioned in the previous paragraph, where participants had the option to respond:\n\n1. Symptom absent\n2. Symptom present but not bothersome\n3. Symptom present and somewhat bothersome, but does not interfere with daily activities or sleep\n4. Symptom present and bothersome because it interferes with daily activities or sleep\n5. Required medical attention",
        "timeFrame": "4 weeks"
      }
    ],
    "secondary": [
      {
        "measure": "Blood pressure",
        "description": "Blood pressure was measured using the Korotkoff auscultation method, These measurements were taken before starting to consume the beverage and at the end of the 4-week trial.\n\nThe outcome measures were the average of the measurements of the 10 participants expressed as mm/Hg of systolic and diastolic pressure.",
        "timeFrame": "4 weeks"
      },
      {
        "measure": "Biomarkers glucose",
        "description": "Glucose was measured by taking a blood sample, These measurements were taken before starting to consume the beverage and at the end of the 4-week trial.\n\nThe outcome measures were the average of the measurements of the 10 participants expressed as mg/dL.",
        "timeFrame": "4 weeks"
      },
      {
        "measure": "Biomarkers cholesterol",
        "description": "Cholesterol was measured by taking a blood sample, These measurements were taken before starting to consume the beverage and at the end of the 4-week trial.\n\nThe outcome measures were the average of the measurements of the 10 participants expressed as mg/dL.",
        "timeFrame": "4 weeks"
      },
      {
        "measure": "Biomarkers triglycerides",
        "description": "Triglycerides were measured by taking a blood sample, These measurements were taken before starting to consume the beverage and at the end of the 4-week trial.\n\nThe outcome measures were the average of the measurements of the 10 participants expressed as mg/dL.",
        "timeFrame": "4 weeks"
      },
      {
        "measure": "Biomarkers creatinine",
        "description": "Creatinine was measured by taking a blood sample, These measurements were taken before starting to consume the beverage and at the end of the 4-week trial.\n\nThe outcome measures were the average of the measurements of the 10 participants expressed as mg/dL.",
        "timeFrame": "4 weeks"
      },
      {
        "measure": "Biomarkers proteinuria",
        "description": "Participants were also asked to provide a urine sample to determine proteinuria.\n\nThese measurements were taken before starting to consume the beverage and at the end of the 4-week trial.\n\nThe results were presented as the number of positive cases for proteinuria, as well as the average of positive cases expressed as mg/dL.",
        "timeFrame": "4 weeks"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 0,
      "exclusionCount": 0,
      "totalCount": 0
    },
    "endpoints": {
      "primaryCount": 2,
      "secondaryCount": 6,
      "otherCount": 0,
      "totalCount": 8
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 50,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T05:06:11.775Z",
  "dataSource": "ClinicalTrials.gov API v2 - Ultimate Complete Collection"
}